Cochlear Boosts Revenue 5%, Prepares Next-Gen Implants for Mid-2025 Launch

• Sales revenue up 5% to $1,170 million, with cochlear implant revenue rising 13% in constant currency
• Statutory net profit increased 7% to $205 million; underlying net profit margin steady at 18%
• Services revenue declined 12% in constant currency, offset by 22% growth in acoustics
• Interim dividend increased 8% to $2.15 per share, payout ratio at 68%